158 related articles for article (PubMed ID: 18980278)
1. Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985-2003.
Copeland G; Datta SD; Spivak G; Garvin AD; Cote ML
Cancer; 2008 Nov; 113(10 Suppl):2946-54. PubMed ID: 18980278
[TBL] [Abstract][Full Text] [Related]
2. Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.
Oh CM; Jung KW; Won YJ; Shin A; Kong HJ; Jun JK; Park SY
PLoS One; 2013; 8(8):e72012. PubMed ID: 23977194
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the impact of human papillomavirus vaccines on high-grade pre-invasive cervical lesions: designing a framework of linked immunization information system and cancer registry data in Michigan.
Potter RC; Flagg EW; Datta SD; Saraiya M; Copeland G
Vaccine; 2015 Mar; 33(11):1400-5. PubMed ID: 25573038
[TBL] [Abstract][Full Text] [Related]
4. Trends in cervical cancer incidence among young black and white women in metropolitan Detroit.
Weiss LK; Kau TY; Sparks BT; Swanson GM
Cancer; 1994 Apr; 73(7):1849-54. PubMed ID: 8137209
[TBL] [Abstract][Full Text] [Related]
5. Incidence of in situ and invasive vulvar cancer in the US, 1998-2003.
Saraiya M; Watson M; Wu X; King JB; Chen VW; Smith JS; Giuliano AR
Cancer; 2008 Nov; 113(10 Suppl):2865-72. PubMed ID: 18980209
[TBL] [Abstract][Full Text] [Related]
6. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.
Wang SS; Sherman ME; Hildesheim A; Lacey JV; Devesa S
Cancer; 2004 Mar; 100(5):1035-44. PubMed ID: 14983500
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer trends in the United States: a 35-year population-based analysis.
Adegoke O; Kulasingam S; Virnig B
J Womens Health (Larchmt); 2012 Oct; 21(10):1031-7. PubMed ID: 22816437
[TBL] [Abstract][Full Text] [Related]
8. [In situ and invasive cervical cancer epidemiology in the province of Girona, Spain 1990-2004: incidence, mortality, survival and screening history].
Castro Marqueta P; Moreno-Crespi J; Buxó-Pujolràs M; Cervantes-Amat M; Pérez-Gómez B; Marcos-Gragera R
Med Clin (Barc); 2011 Feb; 136(5):192-8. PubMed ID: 21051058
[TBL] [Abstract][Full Text] [Related]
9. Burden of cervical cancer in the United States, 1998-2003.
Watson M; Saraiya M; Benard V; Coughlin SS; Flowers L; Cokkinides V; Schwenn M; Huang Y; Giuliano A
Cancer; 2008 Nov; 113(10 Suppl):2855-64. PubMed ID: 18980204
[TBL] [Abstract][Full Text] [Related]
10. Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009.
Flagg EW; Datta SD; Saraiya M; Unger ER; Peters E; Cole L; Chen VW; Tucker T; Byrne MJ; Copeland G; Silva W; Watson M; Weinstock H
Cancer Causes Control; 2014 May; 25(5):571-81. PubMed ID: 24578200
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
Wheeler CM; Hunt WC; Joste NE; Key CR; Quint WG; Castle PE
J Natl Cancer Inst; 2009 Apr; 101(7):475-87. PubMed ID: 19318628
[TBL] [Abstract][Full Text] [Related]
12. Incidence trends in invasive uterine cervix cancer and carcinoma in situ in Incheon, South Korea.
Boo YK; Kim WC; Lee HY; Leem JH; Lee MH; Leem JS
Asian Pac J Cancer Prev; 2011; 12(8):1985-8. PubMed ID: 22292638
[TBL] [Abstract][Full Text] [Related]
13. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity.
Barnholtz-Sloan J; Patel N; Rollison D; Kortepeter K; MacKinnon J; Giuliano A
Cancer Causes Control; 2009 Sep; 20(7):1129-38. PubMed ID: 19253025
[TBL] [Abstract][Full Text] [Related]
14. Recent trends in the epidemiology of cervical neoplasia.
Greenberg RS; Chow WH; Liff JM
Acta Cytol; 1989; 33(4):463-70. PubMed ID: 2750436
[TBL] [Abstract][Full Text] [Related]
15. Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs.
Vänskä S; Luostarinen T; Lagheden C; Eklund C; Kleppe SN; Andrae B; Sparén P; Sundström K; Lehtinen M; Dillner J
Am J Epidemiol; 2021 Apr; 190(4):506-514. PubMed ID: 32639531
[TBL] [Abstract][Full Text] [Related]
16. Uterine cervical carcinoma in Connecticut, 1935-1973: evidence for two classes of invasive disease.
Laskey PW; Meigs JW; Flannery JT
J Natl Cancer Inst; 1976 Nov; 57(5):1037-43. PubMed ID: 1003540
[TBL] [Abstract][Full Text] [Related]
17. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009-2012.
Watson M; Soman A; Flagg EW; Unger E; Deapen D; Chen VW; Peres LC; Copeland G; Tucker TC; Garnett E; Saraiya M
Prev Med; 2017 Oct; 103():60-65. PubMed ID: 28765084
[TBL] [Abstract][Full Text] [Related]
19. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction.
Hopenhayn C; Christian A; Christian WJ; Watson M; Unger ER; Lynch CF; Peters ES; Wilkinson EJ; Huang Y; Copeland G; Cozen W; Saber MS; Goodman MT; Hernandez BY; Steinau M; Lyu C; Tucker TT; Saraiya M
J Low Genit Tract Dis; 2014 Apr; 18(2):182-9. PubMed ID: 24477171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
